Jada G. Hamilton, PhD, MPH

Associate Attending Psychologist; Co-Director, Genomics, Risk & Health Decision-Making Laboratory
Share
Jada Hamilton

Office Phone

646-888-0049

Email

[email protected]

Dr. Jada Hamilton is an Associate Member at Memorial Sloan Kettering Cancer Center, as well as an Associate Attending Psychologist in the Behavioral Sciences Service, Department of Psychiatry and Behavioral Sciences and in the Clinical Genetics Service, Department of Medicine at Memorial Sloan Kettering Cancer Center in New York, New York.

Prior to joining the faculty of Memorial Sloan Kettering, Dr. Hamilton received a BA in Genetics and Psychology from Ohio Wesleyan University (2004), an MA and PhD in Social and Health Psychology from Stony Brook University (2006, 2009), and an MPH from the Mailman School of Public Health at Columbia University (2010).  Dr. Hamilton also completed a postdoctoral fellowship as part of the National Cancer Institute’s Cancer Prevention Fellowship Program.

Dr. Hamilton’s program of research addresses the intersection of behavioral science, cancer prevention, and genomics, with the goal of translating advances in genetic and genomic medicine into improved cancer care that is of high quality, aligned with patient preferences, and ultimately improves public health. She is currently leading multiple studies to examine the effects of novel genomic testing care models and technologies on the decision-making, psychological, and behavioral outcomes of patients and their families. She has authored more than 70 articles in journals including Genetics in Medicine, JCO Precision Oncology and Psycho-Oncology. Dr. Hamilton has received research grant funding from the National Cancer Institute, National Human Genome Research Institute, and the American Cancer Society.

Outside of the lab, Dr. Hamilton enjoys baking and cooking, reading, competing with her pub trivia team, and exploring restaurants throughout New York City and Philadelphia.

Education: PhD, Stony Brook University; MPH, Columbia University

Fellowships: National Cancer Institute

Department & Service: Department of Psychiatry and Behavioral Sciences, Behavioral Sciences Service; Department of Medicine, Division of Solid Tumor Oncology, Clinical Genetics Service

Publications

Hamilton, J. G., Shuk, E., Genoff, M. C., Rodriguez, V. M., Hay, J. L., Offit, K., & Robson, M. E. (2017). Interest and attitudes of patients with advanced cancer with regard to secondary germline findings from tumor genomic profiling. Journal of Oncology Practice, 13(7):e590-e601.

Hamilton, J. G., Genoff, M. C., Salerno, M., Amoroso, K., Boyar, S. R., Sheehan, M., Harlan Fleischut, M., Siegel, B., Arnold, A. G., Salo-Mullen, E. E., Hay, J. L., Offit, K., & Robson, M. E. (2017). Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly-diagnosed breast cancer. Breast Cancer Research and Treatment, 162(2), 297-306.

Hamilton, J. G., Lillie, S. E., Alden, D. L., Scherer, L., Oser, M., Rini, C., Tanaka, M., Baleix, J., Brewster, M., Craddock Lee, S., Goldstein, M. K., Jacobson, R. M., Myers, R. E.., Zikmund-Fisher, B. J., & Waters, E. A. (2017). What is a good medical decision? A research agenda guided by perspectives from multiple stakeholders. Journal of Behavioral Medicine, 40(1), 52-68.

Hamilton, J. G., Hutson, S. P., Moser, R. P., Kobrin, S. C., Frohnmayer, A., Alter, B. P., & Han, P. K. J. (2013). Sources of uncertainty and their association with medical decision making: Exploring mechanisms in Fanconi anemia. Annals of Behavioral Medicine, 46(2), 204-216.

Hamilton, J. G., Lobel, M., & Moyer, A. (2009). Emotional distress following genetic testing for hereditary breast and ovarian cancer: A meta-analytic review. Health Psychology, 28(4), 510-518.

View a full listing of Jada G. Hamilton’s journal articles.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Jada G. Hamilton discloses the following relationships and financial interests:

  • American Cancer Society
    Professional Services and Activities

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: